ABOUT MEDTRACE PHARMA

We are a development stage company aiming to innovate PET diagnostic imaging.

Our team

Martin Stenfeldt

CEO

Rune Wiik Kristensen

COO

Dorte Thulstrup

Regulatory Affairs Manager

Cesare Orlandi

Medical officer

Hans Harms, Ph.D.

VP, aQuant Development

René Duvander

Director, commercial business development

Maja Damby Carøe

Head of quality assurance

Thomas Arnbjerg

Head of software architecture

Thor Brønsvig

Head of controlling and business support

Richard Bebb

Head of technical service

Sascha Wenger-Parving

Product Manager

Kasper Lykkegaard Therkelsen

Project Manager, Design & usability

Teresa Lorrio Gonzales

Sr. SOFTWARE DEVELOPer, medical imaging

Mark Gockenbach

project manager, SoftWare Developmentt

Michelle S. Lee

Project coordinator

Yumi Murakami

Country manager japan

Lars Poulsen Tolbod, Ph.D.

New indications specialist

Peter Larsen, Ph.D.

Advisor, hardware development

Jens Soerensen, M.D., Professor

clinical advisor

Helle Rasmussen

Bookkeeper

Mark Lubberink, Professor

scientific advisor

Rebekka Stenfeldt

STUDENT ASSISTANT,
BUSINESS SUPPORT

Katrine Obel

STUDENT ASSISTANT,
Design & Usability Engineering

Alberte Drivsholm

STUDENT ASSISTANT,
Design & Usability Engineering

Our board of directors

Erik Strömqvist

Chairman

Robert Schier

Director

Claus Berner Møller

Director

Cesare Orlandi

Director

Mads Rasmussen

Vice-chairman

Jens Soerensen, M.D., Professor

Director

Group 6Created with Sketch.

”The availability of a reliable approved system for bed-side production of 15O-water could change 15O-water PET from an exotic research tool to a clinical workhorse”

Martin Stenfeldt, CEO, MedTrace Pharma